Tag: vaccine development company
Australia to purchase 51 million doses of COVID-19 vaccine from Novavax
American vaccine development company Novavax, Inc. has executed an Advance Purchase Agreement with the Commonwealth of Australia for 51 million doses of NVX-CoV2373, its...
Featured Article
Why energy is becoming a strategic asset for manufacturers
Energy is no longer just a cost centre for manufacturers – it is fast becoming a strategic lever for efficiency, resilience and growth.
